Colorectal serrated adenocarcinoma
The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) ranks among the three most common cancers in terms of both cancer incidence and cancer‐related deaths in most Western countries. Serrated adenocarcinoma is a recently described, distinct variant of CRC, accounting for about 7.5% of all CRCs and up to 17.5% of most proximal CRCs. It has been postulated that about 10–15% of sporadic CRCs would have their origin in serrated polyps that harbour a significant malignant potential. These lesions include hyperplastic‐type aberrant crypt foci, hyperplastic polyps, sessile serrated adenomas, admixed polyps and serrated adenomas, and constitute the so‐called ‘serrated pathway’, which is distinct from both the conventional adenoma–carcinoma pathway and the mutator pathway of hereditary non‐polyposis CRC and is characterized by early involvement of oncogenic BRAF mutations, excess CpG island methylation (CIM) and subsequent low‐ or high‐level DNA microsatellite instability (MSI). Methylation of hMLH1 is likely to explain the increased frequency of high‐level MSI (16%) and methylation of MGMT is postulated to explain the low‐level MSI (29%) in serrated adenocarcinomas. Reproducible histopathological criteria for serrated adenocarcinoma have recently been established and they have been qualified by DNA expression analysis for 7928 genes, showing clustering of serrated adenocarcinomas into a molecular entity apart from conventional adenocarcinoma, and representing with distinct down‐regulation of EPHB2, PTCH and up‐regulation of HIF1α.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Prevention of Colorectal Cancer by Colonoscopic Polypectomy
Winawer, S. J., Zauber, A. G., Ho, M. N., O'Brien, M. J., Gottlieb, L. S., Sternberg, S. S., Waye, J. D., Schapiro, M., Bond, J. H., Panish, J. F., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292701 · Cited by 4,592
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130
Clues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710
The evolution of cancer of the colon and rectum
Muto, T., Bussey, H. J. R., & Morson, B. C. (1975) · Cancer · doi:10.1002/cncr.2820360944 · Cited by 2,118
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
RAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224 · cited 1×
“The most common BRAF mutation (V600E, formerly V599E) results in a constitutively activated enzyme.(129) It has been identified in 5–15% of CRCs and is strongly associated with DNA methylation and MSI.”
Background
Cited by
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Okugawa, Y., Grady, W. M., & Goel, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.011 · Cited by 782
Nonpolypoid neoplastic lesions of the colorectal mucosa
Kudo, S. E., Lambert, R., Allen, J. I., Fujii, H., Fujii, T., Kashida, H., Matsuda, T., Mori, M., Saito, H., Shimoda, T., et al. (2008) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2008.07.052 · Cited by 530
The serrated pathway to colorectal carcinoma: current concepts and challenges
Bettington, M., Walker, N., Clouston, A., Brown, I., Leggett, B., & Whitehall, V. (2013) · Histopathology · doi:10.1111/his.12055 · Cited by 502
Sessile Serrated Adenoma (SSA) vs. Traditional Serrated Adenoma (TSA)
Torlakovic, E. E., Gomez, J. D., Driman, D. K., Parfitt, J. R., Wang, C., Benerjee, T., & Snover, D. C. (2008) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318157f002 · Cited by 348
Serrated Polyps and Colorectal Cancer: New Pathway to Malignancy
Noffsinger, A. E. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092317 · Cited by 282
S3-Leitlinie „Kolorektales Karzinom” – Aktualisierung 2008
Schmiegel, W., Reinacher-Schick, A., Arnold, D., Graeven, U., Heinemann, V, Porschen, R., Riemann, J., Rödel, C., Sauer, R., Wieser, M., et al. (2008) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2008-1027726 · Cited by 274
Bennecke, M., Kriegl, L., Bajbouj, M., Retzlaff, K., Robine, S., Jung, A., Arkan, M. C., Kirchner, T., & Greten, F. R. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.013 · Cited by 186
“5% of proximal colorectal cancers, has been proposed to follow an alternative pathway, the so-called serrated route to cancer (Jass, 2007; Makinen, 2007; Noffsinger, 2009).”
BackgroundYu, J., Chen, Y., Fu, X., Zhou, X., Peng, Y., Shi, L., Chen, T., & Wu, Y. (2016) · International Journal of Cancer · doi:10.1002/ijc.30168 · Cited by 176
“It’s recently believed that up to 20% of CRCs arise through a serrated neoplasia pathway.(10,11) There is a growing consensus that SSAs are the precursor lesions of CIMP-high CRCs in the proximal colon because of several similarities between them; most notably their proximal tumor location and their MLH1 methylation a…”
BackgroundCarragher, L. A. S., Snell, K. R., Giblett, S. M., Aldridge, V. S. S., Patel, B., Cook, S. J., Winton, D. J., Marais, R., & Pritchard, C. A. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000099 · Cited by 144
“The concept of a second ‘serrated neoplasia pathway’ has gained growing acceptance in recent years and refers to a pathway involving the progression from hyperplastic polyps to serrated adenomas and serrated carcinomas (Hawkins et al, 2002; Jass, 2007a; Makinen, 2007).”
Caruso, M., Moore, J., Goodall, G. J., Thomas, M., Phillis, S., Tyskin, A., Cheetham, G., Lerda, N., Takahashi, H., & Ruszkiewicz, A. (2009) · Virchows Archiv · doi:10.1007/s00428-009-0731-0 · Cited by 34
Loughrey, M. B. (2020) · Histopathology Reporting · doi:10.1007/978-3-030-27828-1_6 · Cited by 6
Metadata
- Authors
- Mäkinen, M. J.
- Venue
- Histopathology
- Publisher
- Wiley
- Published
- 2006-12-14
- Volume
- 50
- Issue
- 1
- Pages
- 131-150
- ISSN
- 0309-0167 (ISSN-L)
- 1365-2559
- OpenAlex
- W2031284310
- Cited by
- 316
- References
- 143
- FWCI
- 13.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.